http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PE-20040765-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-58 |
| filingDate | 2003-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_214fad0056056bc3241ca29af8ab6b5e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_183c0ee779273bdc8e09dc9f6ee0fbf4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cdf101bebc83bb4e411e5ad2e279a9b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f51cde2700649b231bd68423b3c082a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e721d817d726a0d12a56a8d41c891232 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80553d14c3da98e91b35d063d5bdab09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36326793f5cd2dd51343c4894ea847a1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8f638d7322d37be06ba905301229418 |
| publicationDate | 2004-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | PE-20040765-A1 |
| titleOfInvention | 4-AMINO PIPERIDINES N, N-DISUSTITUTED AS INHIBITORS OF MONOAMINE UPTAKE |
| abstract | REFERS TO COMPOUNDS OF FORMULA I, WHERE n IS 1, 2 OR 3; R1 IS ALKYL (C2-C10), ALKENYL (C2-C10), CYCLOALKYL (C3-C8) OR CYCLOALKYL (C4-C10) -ALKYL, WHERE A CC LINK OF THE ALKYL CYCLE IS REPLACED BY A CO, SC or C = C LINK , AND OPTIONALLY REPLACED BY 1 TO 7 HALOGEN SUBSTITUTES AND / OR WITH 1 TO 3 HYDROXY, CYANE, ALKYL (C1-C4), AMONG OTHERS; R2, R3 AND R4 ARE H, ALKYL (C1-C4), ALKYL (C1-C4) -S (O) x WHERE x IS 0, 1 OR 2, ALCOXI (C1-C4) (OPTIONALLY SUBSTITUTED WITH 1 TO 7 HALOGENS ), CYANE, HALOGEN, AMONG OTHERS; OR R2 AND R3 OR R3 AND R4, TOGETHER FORM AN ADDITIONAL BENZENE RING (OPTIONALLY SUBSTITUTED BY 1 TO 3 HALOGENS, ALKYL (C1-C4) OR ALCOXY (C1-C4); R5 AND R6 ARE H, HALOGEN, ALKYL (C1 -C4), ALCOXY (C1-C4) (OPTIONALLY REPLACED WITH 1 TO 7 HALOGENS); R7 AND R8 ARE HO ALKYL (C1-C4); R9 AND R10 ARE H, HALOGEN, HYDROXY, CYANE, C1-C4 ALKYL OR ALCOXI (C1-C4). PREFERRED COMPOUNDS ARE: N- (1-METHYLPROPYL) -N - {[2- (TRIFLUOROMETHYL) PHENYL] METHYL} PIPERIDIN-4-AMINE, N- (2-METHYLPROPYL) -N - {[4 - (METHOXY) PHENYL] METHYL} PIPERIDIN-4-AMINE, N- (2-METHYLPROPYL) -N - {[4- (CHLORINE) PHENYL] METHYL} PIPERIDIN-4-AMINE, AMONG OTHERS. ALSO REFERS TO A PROCEDURE FOR THEIR PRODUCTION AND A PHARMACEUTICAL FORM CONTAINING IT. THESE COMPOUNDS ARE INHIBITORS OF THE UPTAKE OF SEROTONIN AND / OR NOREPINEPHRINE AND / OR DOPAMINE AND ARE USEFUL FOR THE TREATMENT OF TRANSFERS OF THE CENTRAL OR PERIPHERAL NERVOUS SYSTEM |
| priorityDate | 2002-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 40.